Recent advancements in cancer vaccine development have demonstrated their potential for precise tumor targeting through ...

A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...

Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...

This study developed a pH-responsive nanovaccine (Lyc-OVA) based on Lycium barbarum-derived carbon dots (Lyc-CDs) synthesized ...

Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...

Thymagen (also called thymogen; dipeptide Glu-Trp, EW) is a synthetic peptide analog derived from thymic extracts and regarded in peptide bioregulator research for its putative immunoregulatory and ...

Universal CAR T cells produce rapid remissions and enable allogeneic stem cell transplants in patients with relapsed or refractory T-cell acute lymphoblastic leukemia.

CD8⁺ T cells are central effectors of antitumor immunity, capable of recognizing and eliminating malignant cells. Their presence within tumors often ...